Siluria Technologies received $20 million in funding to commercialize its process for converting methane into fuel and chemicals.
The Series B round was led by Wellcome Trust, a London- based charity that funds health research with a $23 billion investment portfolio, San Francisco-based Siluria said yesterday in a statement. Existing investors Alloy Ventures, Arch Venture Partners, Kleiner Perkins Caufield & Byers, Altitude Life Science Ventures, Lux Capital and Presidio Ventures also participated in the funding.
To contact the reporter on this story: Ehren Goossens in New York at email@example.com
To contact the editor responsible for this story: Will Wade at firstname.lastname@example.org